Axol Bioscience to expand in Edinburgh after $2.8m funding deal

Axol Bioscience has secured $2.8 million (around £2.1 million) in funding, part of which will be used to expand its operations in Edinburgh.

The investment was led by US life sciences specialist BroadOak Capital Partners, with the company’s founding investor, the Roslin Foundation, also participating.